Compare AGRZ & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGRZ | CING |
|---|---|---|
| Founded | 2020 | 2012 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.3M | 40.5M |
| IPO Year | 2025 | 2021 |
| Metric | AGRZ | CING |
|---|---|---|
| Price | $0.41 | $6.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $31.33 |
| AVG Volume (30 Days) | ★ 579.6K | 398.6K |
| Earning Date | 05-22-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2038.10 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $14,879,848.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.19 | ★ N/A |
| Revenue Growth | ★ 200.67 | N/A |
| 52 Week Low | $0.33 | $3.20 |
| 52 Week High | $7.20 | $7.92 |
| Indicator | AGRZ | CING |
|---|---|---|
| Relative Strength Index (RSI) | 38.10 | 52.03 |
| Support Level | $0.40 | $5.47 |
| Resistance Level | $0.44 | $7.92 |
| Average True Range (ATR) | 0.08 | 0.72 |
| MACD | 0.05 | -0.05 |
| Stochastic Oscillator | 28.78 | 33.10 |
Agroz Inc is a vertically integrated agricultural technology (AgTech) company focused on designing, innovating, developing, building, operating and managing large, commercial-scale, industrial-grade indoor CEA vertical farms using CEA practices. Its mission is to improve food safety, food security, and sustainability for society by creating a reliable, accessible food supply through its AgTech products and services. CEA vertical farming is an agricultural method involving crop cultivation through vertically stacked layers in a controlled indoor environment. CEA practices are defined by growing produce in spaces where environmental conditions can be controlled and manipulated to match the needs of specific plants.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.